US 10,870,656 B2Granted

Methods for treatment of heart failure

AssigneeCardurion Pharmaceuticals, LLC

InventorMichael E. Mendelsohn

Life of this patent

Estimating the term…

Abstract

Disclosed are methods, compositions and kits for treating or preventing heart failure. Methods of the invention treating heart failure in a mammal comprising administering to the mammal an effective amount of a thienopyrimidine compound.

Claims9

Dependent claims

A method of treating heart failure in a mammal, the method comprising administering an effective amount of a compound having the structure

or a pharmaceutically acceptable salt thereof.

Dependencies are inferred from the claim text.

Facts

Application: 16/240,393Filed 4 Jan 2019 · continuation
Priority: 7 Jul 2016
Published: US 2019/0211028 A111 Jul 2019
Granted: 22 Dec 2020
Term ends: Not estimatedThe source records don’t support an estimate.

Classification7 codes

C07D 495/04
In which the condensed system contains two hetero rings: ortho-condensed systems
A61K 31/519
Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim: ortho- or peri-condensed with heterocyclic rings
A61K 45/06
Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00: mixtures of active ingredients without…
A61P 9/04
Drugs for disorders of the cardiovascular system: inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Family

Application62/359,695Us provisional application · filed 7 Jul 2016
PCT/US2017/041249Parent of this continuation · filed 7 Jul 2017
US 2019/0211028 A1Pre-grant publication · published 11 Jul 2019
US 10,870,656 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

Building an agent or pulling many patents? Use the API or MCP server instead of scraping pages. Get an API key

patentgrep

Loading patent…

patentgrepSearch patents

Back to results